502 related articles for article (PubMed ID: 6338043)
1. Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man.
FitzGerald GA; Oates JA; Hawiger J; Maas RL; Roberts LJ; Lawson JA; Brash AR
J Clin Invest; 1983 Mar; 71(3):676-88. PubMed ID: 6338043
[TBL] [Abstract][Full Text] [Related]
2. Selective and nonselective inhibition of thromboxane formation.
FitzGerald GA; Oates JA
Clin Pharmacol Ther; 1984 May; 35(5):633-40. PubMed ID: 6370554
[TBL] [Abstract][Full Text] [Related]
3. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects.
Chiabrando C; Rivoltella L; Martelli L; Valzacchi S; Fanelli R
Biochim Biophys Acta; 1992 Feb; 1133(3):247-54. PubMed ID: 1737057
[TBL] [Abstract][Full Text] [Related]
4. Platelet function and biosynthesis of prostacyclin and thromboxane A2 in whole blood after aspirin administration in human subjects.
Mehta JL; Mehta P; Lopez L; Ostrowski N; Aguila E
J Am Coll Cardiol; 1984 Oct; 4(4):806-11. PubMed ID: 6384329
[TBL] [Abstract][Full Text] [Related]
5. Endogenous prostacyclin biosynthesis and platelet function during selective inhibition of thromboxane synthase in man.
FitzGerald GA; Brash AR; Oates JA; Pedersen AK
J Clin Invest; 1983 Oct; 72(4):1336-43. PubMed ID: 6355181
[TBL] [Abstract][Full Text] [Related]
6. Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects.
Patrignani P; Filabozzi P; Patrono C
J Clin Invest; 1982 Jun; 69(6):1366-72. PubMed ID: 7045161
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of thromboxane formation in vivo and ex vivo: implications for therapy with platelet inhibitory drugs.
Reilly IA; FitzGerald GA
Blood; 1987 Jan; 69(1):180-6. PubMed ID: 3790723
[TBL] [Abstract][Full Text] [Related]
8. Differential inhibition by low-dose aspirin of human venous prostacyclin synthesis and platelet thromboxane synthesis.
Hanley SP; Bevan J; Cockbill SR; Heptinstall S
Lancet; 1981 May; 1(8227):969-71. PubMed ID: 6112387
[TBL] [Abstract][Full Text] [Related]
9. Effects of non-steroidal anti-inflammatory drugs on prostacyclin and thromboxane biosynthesis in patients with mild essential hypertension.
Minuz P; Barrow SE; Cockcroft JR; Ritter JM
Br J Clin Pharmacol; 1990 Oct; 30(4):519-26. PubMed ID: 2291866
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin.
Preston FE; Whipps S; Jackson CA; French AJ; Wyld PJ; Stoddard CJ
N Engl J Med; 1981 Jan; 304(2):76-9. PubMed ID: 7003384
[TBL] [Abstract][Full Text] [Related]
11. Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin.
Clarke RJ; Mayo G; Price P; FitzGerald GA
N Engl J Med; 1991 Oct; 325(16):1137-41. PubMed ID: 1891022
[TBL] [Abstract][Full Text] [Related]
12. Differential effect of aspirin on thromboxane and prostaglandin biosynthesis in man.
Ritter JM; Cockcroft JR; Doktor HS; Beacham J; Barrow SE
Br J Clin Pharmacol; 1989 Nov; 28(5):573-9. PubMed ID: 2590611
[TBL] [Abstract][Full Text] [Related]
13. [Effect of flurbiprofen on platelet functions. Study of its interference with the synthesis of platelet thromboxane and production of prostacyclin by the rabbit aorta].
Levy-Toledano S; Maclouf J; Caen J; Bara L; Lecrubier C; Samama M
J Pharmacol; 1983; 14(2):141-50. PubMed ID: 6408316
[TBL] [Abstract][Full Text] [Related]
14. 2,3-Dinor metabolites of thromboxane A2 and prostacyclin in urine from healthy human subjects: diurnal variation and relation to 24h excretion.
Wennmalm A; Benthin G; Granström EF; Persson L; Winell S
Clin Sci (Lond); 1992 Oct; 83(4):461-5. PubMed ID: 1330409
[TBL] [Abstract][Full Text] [Related]
15. Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension.
Benigni A; Gregorini G; Frusca T; Chiabrando C; Ballerini S; Valcamonico A; Orisio S; Piccinelli A; Pinciroli V; Fanelli R
N Engl J Med; 1989 Aug; 321(6):357-62. PubMed ID: 2664523
[TBL] [Abstract][Full Text] [Related]
16. Rapid recovery of in vivo prostacyclin formation after inhibition by aspirin. Evidence from measurements of the major urinary metabolite of prostacyclin by GC-MS.
Vesterqvist O
Eur J Clin Pharmacol; 1986; 30(1):69-73. PubMed ID: 3519239
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of prostacyclin from platelet-derived endoperoxides by cultured human endothelial cells.
Marcus AJ; Weksler BB; Jaffe EA; Broekman MJ
J Clin Invest; 1980 Nov; 66(5):979-86. PubMed ID: 6776148
[TBL] [Abstract][Full Text] [Related]
18. Effects of salicylic and acetylsalicylic acid alone and in combination on platelet aggregation and prostanoid synthesis in man.
Rosenkranz B; Fischer C; Meese CO; Frölich JC
Br J Clin Pharmacol; 1986 Mar; 21(3):309-17. PubMed ID: 3083851
[TBL] [Abstract][Full Text] [Related]
19. Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase.
Reilly IA; Doran JB; Smith B; FitzGerald GA
Circulation; 1986 Jun; 73(6):1300-9. PubMed ID: 2938849
[TBL] [Abstract][Full Text] [Related]
20. Superior antiplatelet action of alternate day pulsed dosing versus split dose administration of aspirin.
Lorenz RL; Boehlig B; Uedelhoven WM; Weber PC
Am J Cardiol; 1989 Nov; 64(18):1185-8. PubMed ID: 2510490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
